Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/002240external-prioritypatent/WO1998055139A1/en
Application filed by Smithkline Beecham PlcfiledCriticalSmithkline Beecham Plc
Priority to NO995940ApriorityCriticalpatent/NO995940L/no
Publication of NO995940D0publicationCriticalpatent/NO995940D0/no
Publication of NO995940LpublicationCriticalpatent/NO995940L/no
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Anvendelse av en leptin-antagonist for fremstilling av et medikament for behandling av lidelser som er et resultat av svikt i insulinsekresjon, hyperglykemi og insulinresistens.
NO995940A1997-06-061999-12-03Anvendelse av leptin antagonister for behandling av diabetes
NO995940L
(no)
Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function
Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
Saredutandi ja selle farmatseutiliselt vastuvõetavate soolade kasutamine meeleoluhäirete, kohanemishäirete või segatüüpi ärev-depressiivsete häirete raviks või vältimiseks kasulike ravimite valmistamiseks